Valuation trends and practices
This edition of KPMG’s Quarterly Brief - International Valuation Newsletter focuses on insights into the value drivers of the healthcare sector, i.e. pharmaceutical and biotechnology companies, with a particular focus on vaccine developers.
We explore a range of questions, including:
In addition, we share with you our summary of key capital market data such as index performance, sector multiples, risk free rate for Austria, equity risk premium for Austria, inflation adjusted risk free rates and country risk premiums for BRICS countries. These can all be found in the final section of this Quarterly Brief.